Pharma Capital
Showing 40 of 40
Name Market Market Cap Share Price Daily Share Movement
abzena-logo.png Abzena plc AIM £70.50m £0.33 -2.94% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £16.19m £0.20 0.00% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £5.78m £0.75 0.00% ico_glass.png
allergytherap.gif Allergy Therapeutics plc AIM £196.06m £0.33 2.33% ico_glass.png
Alliance-logo.png Alliance Pharma plc AIM £256.08m £0.54 0.92% ico_glass.png
Amryt_Pharma_59677939c44cb.png Amryt Pharmaceuticals AIM £45.11m £0.22 -0.46% ico_glass.png
angle-logo.png ANGLE plc AIM £26.28m £0.36 1.13% ico_glass.png
avacta.png Avacta Group Plc AIM £49.25m £0.72 -0.69% ico_glass.png
c4x.png C4X Discovery Holdings plc AIM £35.61m £0.77 0.00% ico_glass.png
clinigen-logo.png Clinigen Group PLC AIM £1,213.84m £10.55 0.29% ico_glass.png
collagen_solutions.png Collagen Solutions PLC AIM £15.85m £0.05 -2.30% ico_glass.png
concepta.png Concepta AIM £11.51m £0.11 -2.33% ico_glass.png
deltex-logo.png Deltex Medical Group plc AIM £10.02m £0.03 2.40% ico_glass.png
e-ther.png e-Therapeutics plc AIM £28.53m £0.11 0.00% ico_glass.png
Ergomed-logo.png Ergomed Plc AIM £72.27m £1.78 4.71% ico_glass.png
fr.png Faron Pharmaceuticals Oy AIM £234.48m £8.40 -2.89% ico_glass.png
FuturaMedical-Logo-1row-RGB.jpg Futura Medical plc. AIM £31.97m £0.27 -0.47% ico_glass.png
genedrive_logo.png Genedrive PLC AIM £6.73m £0.36 0.00% ico_glass.png
imm.gif ImmuPharma PLC AIM £66.26m £0.50 -0.99% ico_glass.png
ID_LOGO.png InnovaDerma LSE £38.35m £3.04 -3.65% ico_glass.png
ixico-logo.png IXICO Plc AIM £8.95m £0.33 0.00% ico_glass.png
MaxCyte.gif MaxCyte AIM £106.67m £2.45 -1.01% ico_glass.png
Midatech_pharma.png Midatech Pharma Plc AIM £36.52m £0.75 -1.32% ico_glass.png
motif-bio-logo-2.png Motif Bio Plc AIM £63.66m £0.33 3.17% ico_glass.png
nanobiotix_logo.png Nanobiotix SA EPA £- £- - ico_glass.png
netscientific-logo.png Netscientific PLC AIM £28.82m £0.42 1.21% ico_glass.png
optibiotix-logo-2.png OptiBiotix Health plc AIM £52.00m £0.65 -2.67% ico_glass.png
redx-logo.png Redx Pharma Plc AIM £40.95m £0.32 -1.52% ico_glass.png
reneuron_logo.png ReNeuron Group Plc AIM £53.80m £0.02 0.00% ico_glass.png
rex_bionics_logo.png Rex Bionics PLC AIM £0.45m £0.02 -30.00% ico_glass.png
sar.jpg Sareum Holdings Plc AIM £23.81m £0.01 5.88% ico_glass.png
scancell.gif Scancell Holdings Plc AIM £37.84m £0.12 -1.02% ico_glass.png
silence-logo-2.jpg Silence Therapeutics plc AIM £128.96m £1.84 -3.22% ico_glass.png
skinbio_therapeutics.png SkinBioTherapeutics PLC AIM £13.35m £0.11 1.12% ico_glass.png
sphere_medical_sponsor_logo.gif Sphere Medical Holding PLC AIM £0.64m £0.00 -15.79% ico_glass.png
summit_corp_logo.png Summit Therapeutics PLC AIM £135.01m £1.91 -2.05% ico_glass.png
synairgen-latest.jpg Synairgen plc AIM £9.73m £0.11 -0.93% ico_glass.png
tissue_regenix_sponsor_logo.png Tissue Regenix Group PLC AIM £142.32m £0.12 0.00% ico_glass.png
Valirx-logo.png ValiRx Plc AIM £1.63m £0.01 3.37% ico_glass.png
WideCellsGroup-2.jpg WideCells Group LSE £8.69m £0.13 -0.74% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.